See also this year's filing and all EDGAR filings for this company.
PDF Report 0001772028_2022_Scopus_BioPharma_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001772028')"} |
Graph
Absolute values for 0001772028, Scopus BioPharma Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 8,184,875 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 2,840 |
3 | remainder_Assets | 0 |
4 | LiabilitiesCurrent | 4,170,266 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 12,611,169 |
9 | ResearchAndDevelopmentExpense | 15,023,450 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 681,210 |
13 | remainder_ComprehensiveNetIncome | -18,586 |
yvar | yval | |
---|---|---|
0 | Assets | 8,187,715 |
1 | Liabilities | 4,170,266 |
2 | Expenses | 27,634,619 |
3 | Revenues | 0 |
4 | StockholdersEquity | 4,017,449 |
5 | NetIncome | -26,953,409 |
6 | ComprehensiveNetIncome | -26,962,702 |
7 | BaseVar | 20,346,198 |
8 | EconomicCapitalRatio | -3.25 |